BSE SMEsme

Goldline Pharmaceutical Ltd.

Get the latest financial performance metrics, timelines, GMP premium trends, and comprehensive details.

Expected GMP Premium

₹15 (34.88%)

Subject to market conditions

Issue Size

₹12 Cr

Aggregate fund raising

IPO Valuation P/E

TBA

Price-to-earnings ratio

Issue Open Date

12 May 2026

Listing schedule timeline

Price Band₹41 - ₹43

Minimum Lot Size3,000 Shares

Issue Close Date14 May 2026

Proposed Listing Date19 May 2026

This record is automatically synchronized with primary markets. GMP updates are crowdsourced and are for informational purpose only.

Goldline Pharmaceutical Ltd. IPO Details, Size, PE Ratio, GMP | India IPO